58 related articles for article (PubMed ID: 25114902)
1. The impact of comorbidity on overall survival in elderly nasopharyngeal carcinoma patients: a National Cancer Data Base analysis.
Huang Y; Chen W; Haque W; Verma V; Xing Y; Teh BS; Brian Butler E
Cancer Med; 2018 Apr; 7(4):1093-1101. PubMed ID: 29493889
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity indices for prognostic evaluation in multiple myeloma: a comprehensive evaluation of the Revised Myeloma Comorbidity Index and other comorbidity indices with pro- and retrospective applications.
Schoeller K; Ihorst G; Reinhardt H; Holler M; Scheubeck S; Herget G; Wäsch R; Engelhardt M
Haematologica; 2024 Apr; 109(4):1279-1284. PubMed ID: 38031759
[No Abstract] [Full Text] [Related]
3. Sex differences in outcomes in multiple myeloma.
Derman BA; Langerman SS; Maric M; Jakubowiak A; Zhang W; Chiu BC
Br J Haematol; 2021 Feb; 192(3):e66-e69. PubMed ID: 33216365
[No Abstract] [Full Text] [Related]
4. Multiple myeloma: patient outcomes in real-world practice.
Yong K; Delforge M; Driessen C; Fink L; Flinois A; Gonzalez-McQuire S; Safaei R; Karlin L; Mateos MV; Raab MS; Schoen P; Cavo M
Br J Haematol; 2016 Oct; 175(2):252-264. PubMed ID: 27411022
[TBL] [Abstract][Full Text] [Related]
5. Validity of the age-adjusted charlson comorbidity index on clinical outcomes for patients with nasopharyngeal cancer post radiation treatment: a 5-year nationwide cohort study.
Yang CC; Chen PC; Hsu CW; Chang SL; Lee CC
PLoS One; 2015; 10(1):e0117323. PubMed ID: 25617629
[TBL] [Abstract][Full Text] [Related]
6. Approaches and Challenges in the Management of Multiple Myeloma in the Very Old: Future Treatment Prospects.
Kaweme NM; Changwe GJ; Zhou F
Front Med (Lausanne); 2021; 8():612696. PubMed ID: 33718400
[TBL] [Abstract][Full Text] [Related]
7. Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart review.
Hájek R; Gonzalez-McQuire S; Szabo Z; Delforge M; DeCosta L; Raab MS; Bouwmeester W; Campioni M; Briggs A
BMJ Open; 2020 Jul; 10(7):e034209. PubMed ID: 32665382
[TBL] [Abstract][Full Text] [Related]
8. Predictive Factors for Early Relapse in Multiple Myeloma after Autologous Hematopoietic Stem Cell Transplant.
Pourmoussa AM; Spielberger R; Cai J; Khoshbin O; Farol L; Cao T; Sahebi F
Perm J; 2019; 23():. PubMed ID: 31926575
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of cardiovascular risk factors and diseases in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Backs D; Saglam I; Löffler C; Ihne S; Morbach C; Brenner S; Angermann C; Ertl G; Frantz S; Störk S; Knop S; Güder G
Oncotarget; 2019 May; 10(34):3154-3165. PubMed ID: 31139330
[TBL] [Abstract][Full Text] [Related]
10. Real-World Clinical Outcomes in Elderly Chinese Patients with Multiple Myeloma: A Single-Center Experience.
Qian X; Chen H; Xia J; Wang J; Zhou X; Guo H
Med Sci Monit; 2018 Aug; 24():5887-5893. PubMed ID: 30138301
[TBL] [Abstract][Full Text] [Related]
11. Cryptogenic and non-cryptogenic liver abscess: A retrospective analysis of 178 cases revealed distinct characteristics.
Chen J; Zhang M; Chen J; Ning Y; Cai X; Zhang L; Xu H; Guo J
J Int Med Res; 2018 Sep; 46(9):3824-3836. PubMed ID: 30091401
[TBL] [Abstract][Full Text] [Related]
12. Prediction of surgical complications in the elderly: Can we improve outcomes?
Mistry PK; Gaunay GS; Hoenig DM
Asian J Urol; 2017 Jan; 4(1):44-49. PubMed ID: 29264206
[TBL] [Abstract][Full Text] [Related]
13. The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.
Gregersen H; Vangsted AJ; Abildgaard N; Andersen NF; Pedersen RS; Frølund UC; Helleberg C; Broch B; Pedersen PT; Gimsing P; Klausen TW
Cancer Med; 2017 Jul; 6(7):1807-1816. PubMed ID: 28639741
[TBL] [Abstract][Full Text] [Related]
14. The Singapore Myeloma Study Group Consensus Guidelines for the management of patients with multiple myeloma.
de Mel S; Chen Y; Gopalakrishnan SK; Ooi M; Teo C; Tan D; Teo ML; Tso AC; Lee LK; Nagarajan C; Goh YT; Chng WJ
Singapore Med J; 2017 Feb; 58(2):55-71. PubMed ID: 27609508
[TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen.
Jung SH; Cho MS; Kim HK; Kim SJ; Kim K; Cheong JW; Kim SJ; Kim JS; Ahn JS; Kim YK; Yang DH; Kim HJ; Lee JJ;
BMC Cancer; 2016 Aug; 16():613. PubMed ID: 27501959
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Freiburg and Charlson comorbidity indices in predicting overall survival in elderly patients with newly diagnosed multiple myeloma.
Kim SM; Kim MJ; Jung HA; Kim K; Kim SJ; Jang JH; Kim WS; Jung CW
Biomed Res Int; 2014; 2014():437852. PubMed ID: 25114902
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Freiburg Comorbidity Index in 466 multiple myeloma patients and combination with the international staging system are highly predictive for outcome.
Kleber M; Ihorst G; Gross B; Koch B; Reinhardt H; Wäsch R; Engelhardt M
Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):541-51. PubMed ID: 23810244
[TBL] [Abstract][Full Text] [Related]
18. Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.
Engelhardt M; Dold SM; Ihorst G; Zober A; Möller M; Reinhardt H; Hieke S; Schumacher M; Wäsch R
Haematologica; 2016 Sep; 101(9):1110-9. PubMed ID: 27479825
[TBL] [Abstract][Full Text] [Related]
19. Prognostic effect of comorbidity indices in elderly patients with multiple myeloma.
Bila J; Jelicic J; Djurasinovic V; Vukovic V; Sretenovic A; Andjelic B; Antic D; Todorovic M; Mihaljevic B
Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):416-9. PubMed ID: 25873436
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
